These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
304 related items for PubMed ID: 36642778
1. Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study. Wang S, Meador KJ, Pawasauskas J, Lewkowitz AK, Ward KE, Brothers TN, Hartzema A, Quilliam BJ, Wen X. Drug Saf; 2023 Mar; 46(3):257-271. PubMed ID: 36642778 [Abstract] [Full Text] [Related]
2. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone. Petrich M, Battin M, Walker E, Brown M, Abdelwahab M, Ma'ayeh M, Rood KM. J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398 [Abstract] [Full Text] [Related]
3. Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy. Suarez EA, Huybrechts KF, Straub L, Hernández-Díaz S, Jones HE, Connery HS, Davis JM, Gray KJ, Lester B, Terplan M, Mogun H, Bateman BT. N Engl J Med; 2022 Dec 01; 387(22):2033-2044. PubMed ID: 36449419 [Abstract] [Full Text] [Related]
4. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome. Sujan A, Cleary E, Douglas E, Aujla R, Boyars L, Smith C, Guille C. Fam Pract; 2022 Mar 24; 39(2):311-315. PubMed ID: 34537839 [Abstract] [Full Text] [Related]
10. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome. Tolia VN, Murthy K, Bennett MM, Miller ES, Benjamin DK, Smith PB, Clark RH. J Perinatol; 2018 Jan 24; 38(1):75-79. PubMed ID: 29048415 [Abstract] [Full Text] [Related]
12. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis. Brogly SB, Saia KA, Walley AY, Du HM, Sebastiani P. Am J Epidemiol; 2014 Oct 01; 180(7):673-86. PubMed ID: 25150272 [Abstract] [Full Text] [Related]
13. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison. Unger A, Jagsch R, Jones H, Arria A, Leitich H, Rohrmeister K, Aschauer C, Winklbaur B, Bäwert A, Fischer G. Addiction; 2011 Jul 01; 106(7):1355-62. PubMed ID: 21438938 [Abstract] [Full Text] [Related]
14. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women. Tran TH, Griffin BL, Stone RH, Vest KM, Todd TJ. Pharmacotherapy; 2017 Jul 01; 37(7):824-839. PubMed ID: 28543191 [Abstract] [Full Text] [Related]
15. Opioid Use Disorder and Perinatal Outcomes. Piske M, Homayra F, Min JE, Zhou H, Marchand C, Mead A, Ng J, Woolner M, Nosyk B. Pediatrics; 2021 Oct 01; 148(4):. PubMed ID: 34479983 [Abstract] [Full Text] [Related]
16. Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study. Lacroix I, Berrebi A, Garipuy D, Schmitt L, Hammou Y, Chaumerliac C, Lapeyre-Mestre M, Montastruc JL, Damase-Michel C. Eur J Clin Pharmacol; 2011 Oct 01; 67(10):1053-9. PubMed ID: 21538146 [Abstract] [Full Text] [Related]